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 ABSTRACT 
 Mastitis induced by Escherichia coli is often char-
acterized by severe clinical signs, indicating a more 
powerful combat of the immune system against the 
pathogen compared with Staphylococcus aureus in-
fections, which are often represented by chronic and 
subclinical diseases. The aim of this study was to test 
the major pathogenic component lipopolysaccharide 
(LPS) from E. coli and lipoteichoic acid (LTA) from 
Staph. aureus for their effects on blood-milk barrier 
integrity and the related transfer of immunoglobulins 
and lactate from blood into milk. A similar somatic cell 
count (SCC) increase was achieved by intramammary 
challenge of 1 quarter of 5 cows with 20 μg of LTA, and 
8 cows with 0.2 μg of LPS (maximum log SCC/mL: 
7). Milk IgG1 concentrations increased in LPS- but not 
in LTA-challenged quarters. Milk IgG2 concentrations 
were increased in treated quarters at 3 h after LPS, 
and 6 h after LTA challenge. Higher maximum levels of 
IgG2 were reached in milk of LPS-treated quarters (173 
± 58 μg/mL) than of LTA-challenged quarters (62 ± 
13 μg/mL). Immunoglobulin G1 and IgG2 levels did not 
change in control quarters. l-Lactate concentrations in 
milk increased 4 h after LPS and 5 h after LTA chal-
lenge and reached higher maximum levels in LPS- (221 
± 48 mg/L) than in LTA-treated quarters (77 ± 18 
mg/L). In conclusion, a mammary inflammation on 
a quantitatively similar level based on SCC increase 
achieves a more efficient transfer of blood components 
such as IgG2 via the blood-milk barrier if induced by 
LPS from E. coli than by LTA from Staph. aureus. This 
pathogen-specific difference may play an important role 
in the cure rate of the respective intramammary infec-
tion, which is usually lower in Staph. aureus- than in E. 
coli-induced mastitis. 
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 Short Communication 
 Intramammary infection with Escherichia coli usu-
ally causes acute clinical mastitis (Hogan and Smith, 
2003), indicating a powerful combat of the immune sys-
tem against the pathogen. In contrast, intramammary 
Staphylococcus aureus infections are often characterized 
by chronic and subclinical diseases (Sutra and Poutrel, 
1994), and the pathogen seems to be able to prevent 
significant activity of the immune system. Lipoteichoic 
acid (LTA) and LPS are cell wall components of Staph. 
aureus and E. coli, respectively, which are generally ac-
cepted as major bacterial components that induce the 
mammary immune defense. These cell wall components 
are experimentally used to investigate the mammary 
immune response (Schmitz et al., 2004; Werner-Misof 
et al., 2007; Rainard et al., 2008). Choosing dosages to 
standardize the immune response quantitatively based 
on a similar SCC increase allowed the study of qualita-
tive differences between these pathogenic components 
(Wellnitz et al., 2011). Differences in the induction 
of the mammary immune response by intramammary 
challenge with LPS and LTA were shown by a differ-
ent induction of expression of different immune factors 
(Wellnitz et al., 2011), which most likely plays a role in 
the development of different mastitis severities. 
 During inflammation of the mammary gland, a mas-
sive leakage of blood constituents into milk occurs due 
to blood-milk barrier alteration (Burton and Erskine, 
2003). Besides SCC, the concentrations of several other 
parameters increase in milk in response to inflamma-
tion of the mammary gland. Not all of these parameters 
may contribute to the immune response. Immunoglobu-
lin G is the major immunoglobulin in ruminant milk 
(Butler, 1983). The subclass IgG1 is the predominant 
antibody type in milk from healthy quarters because 
of an active, selective IgG1 transport across the blood-
milk barrier via the neonatal Fc receptor (FcRn) system 
(Baker et al., 2009). In mastitic milk, IgG2 becomes 
the predominant antibody (Caffin and Poutrel, 1988). 
It is considered to be the main opsonin supporting 
neutrophil phagocytosis in the bovine mammary gland 
and, therefore, plays an important role in the combat 
against mastitis pathogens (Burton and Erskine, 2003). 
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l-Lactate (hereafter referred to as lactate) is another 
blood component that increases in milk during mastitis 
and is proposed to be used as an early indicator to 
detect mastitis (Davis et al., 2004). Leukocytes as a 
source of lactate in milk during an immune response 
have been considered (Davis et al., 2004). Recently, we 
described the blood as a major source of milk lactate 
that leaks into milk as a result of the impairment of the 
blood-milk barrier during the immune response (Lehm-
ann et al., 2013). The aim of the current study was to 
investigate the transfer of immunoglobulins and lactate 
from blood into milk due to a change in the blood-milk 
barrier integrity after an intramammary challenge with 
LPS from E. coli and LTA from Staph. aureus with a 
comparable SCC increase in milk.
In 13 dairy cows, a similar SCC increase (maximum 
log SCC/mL: 7) was achieved by intramammary chal-
lenge of 1 quarter with 20 μg of LTA (n = 5) from 
a Staph. aureus strain that induced a chronic bovine 
mastitis, or with 0.2 μg of LPS (n = 8) from E. coli that 
induced acute bovine mastitis, as previously described 
(Figure 1; Wellnitz et al., 2011). In plasma (jugular 
vein) and milk samples (~10 mL) taken hourly from 
challenged and control quarters, IgG1 and IgG2 concen-
trations were analyzed using ELISA (bovine IgG1/IgG2 
ELISA Quantitation Set; Bethyl Laboratories Inc., 
LuBioScience GmbH, Lucerne, Switzerland). The pro-
cedure was performed according to the manufacturer’s 
protocol. A blocking reagent consisting of fish gelatin 
[1 mL of fish skin gelatin (G7765; Sigma-Aldrich, Stein-
heim, Germany) in 20 mL of bidistilled water] was used 
to avoid matrix effects. Coefficients of variation, calcu-
lated using a control sample on each plate, were 10 and 
20% within and between assays, respectively. Lactate 
concentrations were measured using the test kit Lac-
tate PAP (bioMérieux, Marcy l’Étoile, France) with an 
automated analyzer (Cobas Mira; Roche Diagnostics 
International AG, Rotkreuz, Switzerland) according to 
the manufacturer’s instructions.
Data are presented as means ± standard error of the 
mean. Lactate concentrations are presented and statis-
tically evaluated on a logarithmic scale (log10) to ensure 
normal distribution. Differences within treatment group 
to time point 0 and between-LPS and -LTA treatments 
within each time point (hourly) were tested for signifi-
cance (P < 0.05) by ANOVA using PROC MIXED SAS 
(1999–2001, release 8.02; SAS Institute Inc., Cary, NC). 
The model included time, treatment, and their interac-
tion as fixed effects, and quarter within cow as repeated 
subject. A Tukey-Kramer adjustment was used to com-
pensate for multiple comparisons. The significant (P < 
0.001) Pearson correlation coefficient (SigmaPlot v11; 
Systat Software Inc., Chicago, IL) between SCC and 
IgG1 and IgG2 in LPS-challenged quarters was 0.42 and 
0.33, respectively, and 0.45 and 0.68 between SCC and 
IgG1 and IgG2 in LTA-challenged quarters, respectively.
In blood IgG1 and IgG2, concentrations were 16.5 ± 
1.1 mg/mL and 35.4 ± 6.8 mg/mL, respectively, and 
did not change throughout the experiment. Although 
IgG concentrations in serum are known to be variable 
due to different factors such as age and lactational 
stage (Mallard et al., 1983), these are relatively high 
values compared with those in other studies where 
concentrations around 10 mg/mL were found for both 
immunoglobulins (Butler, 1983; Caffin and Poutrel, 
1988). Reasons for that remain unclear. The test kits 
were validated according the manufacturer recommen-
dations. Milk IgG1 concentrations (Figure 2A) were 68 
± 6, 63 ± 5, and 83 ± 12 μg/mL in control, LPS-, and 
LTA-challenged quarters before (0 h) challenge, respec-
tively. In LPS-challenged quarters, IgG1 concentrations 
increased at 4 and 5 h and from 7 h after challenge until 
the end of the experiment. The maximum of 105 ± 13 
μg/mL was reached 5 h after challenge. In control and 
LTA-challenged quarters, milk IgG1 concentrations did 
not significantly increase.
Milk IgG2 concentrations (Figure 2 B) were 30 ± 6, 
32 ± 8, and 23 ± 8 μg/mL, in control, LPS-, and LTA-
challenged quarters before (0 h) challenge, respectively. 
Milk IgG2 concentrations increased at 3 h in LPS-
challenged quarters, reached the maximum of 173 ± 58 
μg/mL at 6 h after challenge, and stayed elevated until 
the end of the experiment. In LTA-challenged quarters, 
IgG2 was increased at 6 h, reached a maximum of 67 
± 9 μg/mL at 8 h, and stayed elevated until 11 h after 
Figure 1. Milk SCC in LPS-challenged quarters (□; n = 8), in 
lipoteichoic acid (LTA)-challenged quarters (; n = 5), and in control 
quarters (x; n = 13). Means without common letters (a–c) are signifi-
cantly different between groups within a time point (P < 0.05). Data 
are presented as means ± SEM. Reproduced with permission from 
Wellnitz et al. (2011).
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challenge. In control quarters, milk IgG2 concentrations 
did not significantly increase.
The present study clearly shows that LPS of E. coli 
obviously opens the blood-milk barrier to a greater 
extent than LTA from Staph. aureus, despite a simi-
lar SCC increase in response to both treatments. This 
mechanism could be involved in the mainly chronic 
development of mastitis by Staph. aureus because an 
insufficient amount of antibodies and other immune 
factors from blood are transferred into milk due to a 
reduced opening of the blood-milk barrier induced by 
these bacteria.
Concentrations of IgG2 in milk raised to a greater 
extent (5 fold after LPS challenge) than IgG1 (3 fold af-
ter LPS challenge) although these molecules have com-
parable molecular weights of approximately 160 kDa 
(Butler, 1983) and should be able to pass the blood-
milk barrier in a comparable way. The IgG1:IgG2 ratio 
in milk at 5 h after LPS challenge was 1:1.5, whereas 
the ratio in blood was 1:2.1. This was mainly due to 
the specific transport of IgG1 (Mayer et al., 2005) that 
was also responsible for a 2.5:1 ratio in milk before LPS 
challenge. In addition, specific transport of IgG2 has 
been discussed (Newby and Bourne, 1977) and binding 
of IgG2 to mammary epithelial cells has been reported 
(Sasaki et al., 1977). However, during lactation of the 
healthy mammary gland, passive transfer of IgG2 from 
the blood is assumed (Guidry et al., 1980).
As IgG2 plays a particular role in the mammary 
immune defense, the availability of antibodies in the 
milk can be crucial for mastitis defense, specifically if 
antibodies against the invading mastitis pathogens are 
available in the blood. Although IgG2 also enter the 
milk bound to PMNL (Butler, 1983), the majority of 
milk IgG2 that appear in milk during mammary inflam-
mation leak into mammary gland from the blood (Bur-
ton and Erskine, 2003). That differences in the IgG2 
content in the milk during mastitis can depend on the 
pathogen has been reported (Caffin and Poutrel, 1988).
Lactate is another blood component whose appear-
ance in milk was tested with the intramammary LPS 
or LTA challenge. The blood lactate concentration was 
54.9 ± 1.2 mg/L before LPS challenge and did not 
change throughout the experiment. Lactate concentra-
tions in milk (Figure 3) were increased at 4 h after 
challenge in LPS-treated quarters and 5 h after chal-
lenge in LTA-treated quarters and both stayed elevated 
until the end of the experiment. At 4 h after challenge 
to 11 h after challenge, the lactate concentrations in 
milk were higher in LPS- than in LTA-treated quarters. 
This greater increase in lactate concentration in milk of 
quarters challenged with LPS compared with quarters 
challenged with LTA also shows a different character-
istic in the change of blood-milk barrier permeability 
in response to E. coli compared with Staph. aureus 
endotoxin. The small molecular size (90 Da) of lactate 
facilitates transfer from blood into milk. However, milk 
concentration of lactate increased up to 4.0-fold higher 
levels of those in blood (220.7 ± 48.1 mg/L) at 8 h 
after LPS challenge and to 1.4 fold (76.8 ± 18.3 mg/L) 
10 h after LTA challenge. This effect was seen before 
(Lehmann et al., 2013). This effect was suggested to be 
due to additional lactate production and release during 
anaerobic metabolism by milk and epithelial cells in the 
gland (Silanikove et al., 2011) or to be an effect of an 
Figure 2. Milk IgG1 (A) and IgG2 (B) concentrations in LPS-
challenged quarters (□; n = 8), in lipoteichoic acid (LTA)-challenged 
quarters (; n = 5), and in control quarters (x; n = 13). * indicates 
the first and subsequent time points with a significant (P < 0.05) 
difference compared with time 0; # indicates significant (P < 0.05) 
differences between LPS- and LTA-challenged quarters within a time 
point. Data are presented as means ± SEM.
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additional transporter system for lactate, which could 
be via aquaporins, as aquaporins transport lactate 
(Conde et al., 2010) and aquaporins are present in the 
bovine mammary gland (Mobasheri et al., 2011).
Mammary challenge equalized for SCC increases 
produces a greater and differential permeability of the 
blood-milk barrier for immunoglobulins when induced 
by LPS from E. coli compared with LTA from Staph. 
aureus. Thus, more efficient transfer of blood compo-
nents such as IgG2 is achieved with E. coli, which pre-
dominantly induces acute and severe mastitis compared 
with LTA from Staph. aureus, which is responsible for 
more chronic and subclinical mastitis. This effect could 
have an important influence on the cure rate of the 
respective IMI, which is usually lower in Staph. aureus- 
than in E. coli-induced mastitis, specifically if antibod-
ies against the mastitis pathogen are present in the 
blood (e.g., after vaccination).
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